Savara stock sits 26.39 percent below its 52-week high

Published on 10/01/2026 at 18:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Savara stock costs EUR 4.59 on October 1, 2026 versus EUR 4.56, plus 0.66 percent. Second-quarter loss was USD 0.16 per share versus USD 0.14 expected.

SVRA, US8051111016, Illustration mit AI erstellt.

Savara stock (ISIN US8051111016) was trading at EUR 4.59 at Lang & Schwarz on October 1, 2026 at 6:32 p.m. CEST, up 0.66 percent versus the EUR 4.56 prior close. The primary-market quote was USD 5.16, placing the stock 26.39 percent below its USD 7.01 52-week high.

Stock remains below yearly high

The Nasdaq-listed biotechnology company has a market capitalization of USD 1.1 billion as of October 1, 2026. Its 52-week range is USD 3.34 to USD 7.01, so the current USD 5.16 quote sits closer to the middle of the annual range than to its upper boundary.

The euro quotation and the primary-market quotation reflect different venues and currencies. For German investors, the Lang & Schwarz price is the relevant reference here, while the Nasdaq figures show where the U.S. listing stood during its October 1 session.

Second-quarter loss missed estimates

MarketBeat reported that Savara posted a second-quarter 2026 loss of USD 0.16 per share on August 11, 2026, versus a consensus loss of USD 0.14 per share. The USD 0.02 shortfall gives the stock a clear counterweight to the positive analyst consensus.

The same MarketBeat report lists six buy ratings, one strong-buy rating and one sell rating among eight covering brokerages, with an average 12-month price target of USD 10.00. Savara separately reported its second-quarter results and business update on August 11, 2026.

Next report due November 5

Investing.com lists November 5, 2026 as Savara's next earnings date. The scheduled report will give investors a fresh measure of cash use and development progress around molgramostim, the company's inhaled treatment candidate for autoimmune pulmonary alveolar proteinosis.

EUR 4.59 after-hours quote

Savara was trading at EUR 4.59 at Lang & Schwarz on October 1, 2026 at 6:32 p.m. CEST, plus 0.66 percent versus the EUR 4.56 prior close of September 30, 2026. The stock's primary exchange is Nasdaq, where the quote was USD 5.16 during the October 1 session.